# Immucell Corp: Form 8-K, filed Jul 28, 2022

- Company: [Immucell Corp](/companies/iccc.md) (CIK 811641)
- Form: 8-K
- Filed: 2022-07-28
- Accepted by EDGAR: Jul 27, 2022, 20:05 ET
- Period: 2022-07-27
- Accession: 0001213900-22-042127
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/811641/000121390022042127/ea163449-8k_immucell.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/811641/000121390022042127/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/811641/000121390022042127/ea163449-8k_immucell.htm

Filed Jul 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-042127. Last ingested by Listed: Nov 13, 2026, 16:08 ET. No prices; not investment advice.
